negative for mutations of the SLOS gene. Baseline demographics, ovarian reserve, IVF laboratory outcomes, embryonic aneuploidy, and embryo transfer outcomes were compared between SLOS heterozygotes and controls. A sub-analysis restricted to patients undergoing single euploid FETs was conducted to assess the effect of SLOS heterozygosity on embryo transfer outcome. Student's t-test, chi-square test, and multivariate linear and binary logistic regression models were used for data analysis. A mixed model was used to account for patients that underwent multiple cycles.
Results:
SLOS mutation carriers (n=55) were compared to non-carriers (n=1214). Baseline demographic factors, ovarian reserve, cycle IVF cycle characteristics, embryonic aneuploidy screening results and embryo transfer outcome are shown in Table 1 . When controlling for age, SLOS heterozygosity did not impact AMH ( =-0.54, p=0.4) or BAFC ( =0.74, p=0.5). Controlling for age and AMH, SLOS carrier status was not seen to impact oocyte yield ( =-0.2, p=0.9), fertilization ( =-0.07, p=0. 
Conclusion:
In the first study to evaluate the effect of SLOS heterozygosity on female reproductive health, our results demonstrate that carriers have ovarian reserve and ART outcome similar to that of non-carriers. Despite having reduced cholesterol biosynthesis to support steroidogenesis, ovarian response and embryo quality were not adversely affected. A possible explanation is that compensation occurs via alternative pathways of sex hormone production (B-ring unsaturated equine-like steroids derived from accumulated 7-dehydrocholesterol). Alternatively, reduced DHCR7 function may facilitate the production of sufficient cholesterol to support normal reproductive function. Identifying and understanding how perturbations in genes related to lipid metabolism impact reproductive function is essential and should be studied outside of the ART setting to assess whether alterations in steroidogenesis can significant impact menstrual function, ovulation, and the hypothalamic-pituitary-ovarian axis. 
